CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 73 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $169,535 | -54.7% | 29,030 | -67.4% | 0.00% | -100.0% |
| Q2 2022 | $374,000 | +161.5% | 89,146 | +96.4% | 0.00% | – |
| Q4 2021 | $143,000 | -41.6% | 45,383 | -39.5% | 0.00% | -100.0% |
| Q3 2021 | $245,000 | +184.9% | 74,953 | +266.4% | 0.00% | – |
| Q2 2021 | $86,000 | -67.3% | 20,455 | -61.2% | 0.00% | -100.0% |
| Q1 2021 | $263,000 | +6.9% | 52,681 | +170.6% | 0.00% | 0.0% |
| Q4 2020 | $246,000 | +969.6% | 19,465 | +399.9% | 0.00% | – |
| Q3 2019 | $23,000 | -98.1% | 3,894 | -96.2% | 0.00% | -100.0% |
| Q2 2019 | $1,223,000 | +51.5% | 101,897 | +69.8% | 0.01% | -33.3% |
| Q1 2014 | $807,000 | – | 60,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 4,420,349 | $25,814,838 | 3.96% |
| Parkman Healthcare Partners LLC | 1,203,484 | $7,028,347 | 1.87% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,002,783 | $5,856,253 | 1.26% |
| TANG CAPITAL MANAGEMENT LLC | 1,150,000 | $6,716,000 | 0.98% |
| BVF INC/IL | 3,629,000 | $21,193,360 | 0.89% |
| Nantahala Capital Management | 1,732,388 | $10,117,146 | 0.66% |
| AWM Investment Company, Inc. | 666,661 | $3,893,300 | 0.56% |
| INGALLS & SNYDER LLC | 1,295,833 | $7,568 | 0.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 200,800 | $1,172,672 | 0.36% |
| Kensington Investment Counsel, LLC | 58,599 | $342,218 | 0.27% |